成大骨鬆新藥技轉藥廠 4億元天價破紀錄 - 生技
By Genevieve
at 2012-05-15T13:45
at 2012-05-15T13:45
Table of Contents
※ [本文轉錄自 Gossiping 看板 #1FiUXsyH ]
作者: sheepxo ((羊臣又)) 看板: Gossiping
標題: [新聞] 成大骨鬆新藥技轉藥廠 4億元天價破紀錄
時間: Tue May 15 13:24:03 2012
成大骨鬆新藥技轉藥廠 4億元天價破紀錄
2012年05月15日12:36
成大醫學院生物化學暨分子生物學研究所教授張明熙研究團隊,首度研發治療骨質疏鬆的
「阻斷介白素-20」單株抗體新藥,以技轉金額1330萬美元(約新台幣4億元)的天價,成
功技轉歐洲第2大藥廠諾和諾德,刷新台灣技轉金額紀錄。
張明熙研究團隊成功發現人體血清「介白素-20濃度和骨質疏鬆有密切關係,並找出抑制
「介白素-20」的單株抗體,可阻止骨質疏鬆症並增加骨質密度,去年9月登上國際期刊《
自然綜說風濕病學期刊》(Nature Reviews Rheumatology)和《科學-產業技轉期刊》
(Science-Business eXchange),並取得美國專利。
諾和諾德藥廠今天和成大進行簽約記者會,除4億元的技轉金額外,並提供張明熙研究團
隊每年100萬元美金的研究費。成大將撥6成技轉金額給張明熙。
http://www.appledaily.com.tw/realtimenews/article/new/20120515/122806/1
有圖!
--
作者: sheepxo ((羊臣又)) 看板: Gossiping
標題: [新聞] 成大骨鬆新藥技轉藥廠 4億元天價破紀錄
時間: Tue May 15 13:24:03 2012
成大骨鬆新藥技轉藥廠 4億元天價破紀錄
2012年05月15日12:36
成大醫學院生物化學暨分子生物學研究所教授張明熙研究團隊,首度研發治療骨質疏鬆的
「阻斷介白素-20」單株抗體新藥,以技轉金額1330萬美元(約新台幣4億元)的天價,成
功技轉歐洲第2大藥廠諾和諾德,刷新台灣技轉金額紀錄。
張明熙研究團隊成功發現人體血清「介白素-20濃度和骨質疏鬆有密切關係,並找出抑制
「介白素-20」的單株抗體,可阻止骨質疏鬆症並增加骨質密度,去年9月登上國際期刊《
自然綜說風濕病學期刊》(Nature Reviews Rheumatology)和《科學-產業技轉期刊》
(Science-Business eXchange),並取得美國專利。
諾和諾德藥廠今天和成大進行簽約記者會,除4億元的技轉金額外,並提供張明熙研究團
隊每年100萬元美金的研究費。成大將撥6成技轉金額給張明熙。
http://www.appledaily.com.tw/realtimenews/article/new/20120515/122806/1
有圖!
--
Tags:
生技
All Comments
By Odelette
at 2012-05-17T10:02
at 2012-05-17T10:02
By Gilbert
at 2012-05-19T02:30
at 2012-05-19T02:30
By George
at 2012-05-20T04:17
at 2012-05-20T04:17
By Gilbert
at 2012-05-24T17:08
at 2012-05-24T17:08
By Zanna
at 2012-05-27T19:02
at 2012-05-27T19:02
By Queena
at 2012-06-01T18:41
at 2012-06-01T18:41
By Kristin
at 2012-06-02T20:16
at 2012-06-02T20:16
By Enid
at 2012-06-05T16:25
at 2012-06-05T16:25
By Andy
at 2012-06-06T17:47
at 2012-06-06T17:47
By Ursula
at 2012-06-08T06:19
at 2012-06-08T06:19
By Poppy
at 2012-06-11T12:58
at 2012-06-11T12:58
By Elizabeth
at 2012-06-13T08:35
at 2012-06-13T08:35
By Rebecca
at 2012-06-15T02:21
at 2012-06-15T02:21
By Jacob
at 2012-06-17T10:28
at 2012-06-17T10:28
By Valerie
at 2012-06-19T06:25
at 2012-06-19T06:25
By Joseph
at 2012-06-24T03:44
at 2012-06-24T03:44
By Belly
at 2012-06-25T02:12
at 2012-06-25T02:12
By Rosalind
at 2012-06-28T18:13
at 2012-06-28T18:13
By Erin
at 2012-07-03T11:15
at 2012-07-03T11:15
By Linda
at 2012-07-07T04:48
at 2012-07-07T04:48
By Puput
at 2012-07-08T07:44
at 2012-07-08T07:44
By Queena
at 2012-07-12T12:42
at 2012-07-12T12:42
By Bethany
at 2012-07-13T15:19
at 2012-07-13T15:19
By Rebecca
at 2012-07-16T04:14
at 2012-07-16T04:14
By Hazel
at 2012-07-19T01:06
at 2012-07-19T01:06
By Callum
at 2012-07-22T13:09
at 2012-07-22T13:09
By Frederic
at 2012-07-26T21:11
at 2012-07-26T21:11
By James
at 2012-07-29T21:02
at 2012-07-29T21:02
By Zora
at 2012-07-31T21:59
at 2012-07-31T21:59
By Bethany
at 2012-08-01T10:34
at 2012-08-01T10:34
By Kama
at 2012-08-02T14:31
at 2012-08-02T14:31
By Charlotte
at 2012-08-05T03:37
at 2012-08-05T03:37
By Ingrid
at 2012-08-08T14:08
at 2012-08-08T14:08
By Jack
at 2012-08-08T22:14
at 2012-08-08T22:14
By Olga
at 2012-08-13T11:26
at 2012-08-13T11:26
By Andrew
at 2012-08-16T18:36
at 2012-08-16T18:36
By Carol
at 2012-08-16T21:03
at 2012-08-16T21:03
Related Posts
想請問台欣生技的環境如何?
By Elvira
at 2012-05-14T21:54
at 2012-05-14T21:54
業務的未來發展性!?
By Liam
at 2012-05-14T21:44
at 2012-05-14T21:44
「2012台北生技獎」徵件開始
By Madame
at 2012-05-13T07:01
at 2012-05-13T07:01
醫技版的成立
By Jack
at 2012-05-12T23:09
at 2012-05-12T23:09
被老闆糟蹋
By Rachel
at 2012-05-09T19:30
at 2012-05-09T19:30